Nexstim Plc

Equities

NXTMH

FI4000506811

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Helsinki Other stock markets 11:02:01 2024-04-26 am EDT			5-day change	1st Jan Change
2.26 ^EUR	+1.35%		-0.44%	-23.13%

Apr. 22	Nexstim Wins Order for Navigated Brain Stimulation System in US	MT
Apr. 22	Nexstim Receives NBS 6 System Order from Clinic in Florida, US	CI

Nexstim Plc Receives Nexstim NBS System 5 Order from Europe for Neurosurgery and Neuroscience Use

December 22, 2023 at 02:00 am EST

Nexstim Plc (has received an order for an NBS System 5. The system will mainly be used for neurosurgery and possible neuroscience use in the future. Nexstim?s NBS (Navigated Brain Stimulation) System 5 is CE marked and FDA approved for presurgical mapping of the speech and motor cortices of the brain.

Latest news about Nexstim Plc

Nexstim Wins Order for Navigated Brain Stimulation System in US	Apr. 22	MT
Nexstim Receives NBS 6 System Order from Clinic in Florida, US	Apr. 22	CI
Nexstim Receives NBS System 5 Order from Neurosurgery Customer in Germany	Feb. 28	CI
Transcript : Nexstim Plc, 2023 Earnings Call, Feb 27, 2024	Feb. 27
Nexstim Plc Provides Sales Guidance for the Year 2024	Feb. 27	CI
Nexstim Plc Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Finland’s Nexstim Bags Brain Stimulation System Order From US	Jan. 10	MT
Nexstim Receives NBS System 5 Order from Healthcare Services Group in the US	Jan. 10	CI
Nexstim Secures Minority Stake in US-based Management Services Organization	Jan. 04	MT
Nexstim Plc Updates Earnings Guidance for the Year 2023	Jan. 02	CI
Nexstim Receives Nexstim NBS System 5 Order from Distributor in Europe	Dec. 29	CI
Nexstim Wins Order for Brain Simulation System in Europe	Dec. 29	MT
Nexstim Plc Receives Nexstim NBS System 5 Order from Europe for Neurosurgery and Neuroscience Use	Dec. 22	CI
Finland's Nexstim Receives Order for NBS 6 Systems	Dec. 21	MT
Nexstim Plc Receives Order for Two NBS 6 Systems from Distributor	Dec. 21	CI
Nexstim Plc Receives an NBS (Navigated Brain Stimulation) 6 System Order from the Center for Integrative Neuroscience, A New Clinic Located in Traverse City, Michigan	Dec. 20	CI
Finland’s Nexstim Secures Brain Stimulation System Order From Germany	Dec. 19	MT
Hospital in Germany Orders Nexstim NBS System 5	Dec. 19	CI
Nexstim Plc Releases New System Functionalities for Research Use in Europe	Dec. 04	CI
Nexstim Receives NBS System 6 Order from Hospital in United States	Nov. 20	CI
Nexstim plc Announces Board Appointments	23-10-24	CI
Nexstim Wins Order for Navigated Brain Stimulation System in Finland	23-10-20	MT
Nexstim plc Wins Tender Process Resulting in Procurement Decision	23-10-20	CI
Nexstim Receives NBS System 5 Order in Europe	23-10-05	CI
Nexstim Wins Order for Navigated Brain Stimulation System in Europe	23-09-26	MT

Chart Nexstim Plc

Duration

Period

More charts

Company Profile

Nexstim Oyj is a Finland-based medical technology company. It is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Companyâs systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-02 - American Association of Neurological Surgeons Scientific Meeting

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.26 EUR

Average target price

3 EUR

Spread / Average Target

+32.74%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
NEXSTIM PLC	-23.13%	16.32M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B
RESMED, INC.	+26.76%	32.03B

Other Advanced Medical Equipment & Technology